[Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
D000328:Adult; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D014869:Water Intoxication / Q000517:prevention & control
D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin
Schwartz-Bartter-syndroma hosszú DDAVP kezelés után diabetes insipidusos betegben.